Skip to main
BDX

BDX Stock Forecast & Price Target

BDX Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 20%
Hold 47%
Sell 0%
Strong Sell 0%

Bulls say

Becton Dickinson is a global healthcare company with a focus on organic growth and a strong track record of expected EPS performance. Potential downside scenarios and concerns around sustainability are being addressed, while investments in commercial growth and shareholder returns are expected to support the company's position as a dominant player in the industry.

Bears say

Becton Dickinson is facing multiple headwinds in its four business units, including tariff uncertainty, supply chain issues, and declining organic revenue growth. Despite recent efforts to increase diversity in its workforce, BD may struggle to meet its long-term margin targets and could face challenges in stabilizing its vaccine business. Additionally, with only a limited EPS flow-through from the company's recent guidance raise, it appears that BD's financials may continue to experience underperformance.

BDX has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 20% recommend Buy, 47% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Becton, Dickinson and Co. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Becton, Dickinson and Co. (BDX) Forecast

Analysts have given BDX a Buy based on their latest research and market trends.

According to 15 analysts, BDX has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $188.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $188.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Becton, Dickinson and Co. (BDX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.